Fady Ibraham Malik, EVP Research & Development at CYTOKINETICS INC (CYTK), sold 3,500 shares at $68.29 ($239K) on 2026-09-22, disclosed to the SEC on 2026-09-22.
Seasonal sale ($239k) by EVP Research & Development — this insider has traded CYTK in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CYTK | SELL | 2026-07-23 | $282K | — | Filing → |
| CYTK | SELL | 2026-07-07 | $303K | — | Filing → |
| CYTK | SELL | 2026-06-23 | $278K | — | Filing → |